Alcohol Abuse Clinical Trial
Official title:
Motivational Interviewing Delivered by Existing Prison Staff: A Randomized Controlled Study of Effectiveness on Substance Use After Release
Verified date | October 2003 |
Source | Karolinska Institutet |
Contact | n/a |
Is FDA regulated | No |
Health authority | Sweden: Regional Ethical Review Board |
Study type | Interventional |
Motivational Interviewing (MI) is a communication style demonstrated to decrease drug and
alcohol use. A five session MI intervention (BSF) was implemented in the Swedish
correctional system. The intervention was delivered by counsellors with workshop only MI
training (BSF) or by counsellors with workshop MI training followed by peer group
supervision based on audio taped feedback (BSF+).
Aim was to examine whether BSF in prisons reduces drug and alcohol use more effectively than
interviews conducted according to the usual planning interview routine (UPI).
Status | Completed |
Enrollment | 296 |
Est. completion date | July 2008 |
Est. primary completion date | March 2007 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 20 Years to 50 Years |
Eligibility |
Inclusion Criteria: - Born between 01-01-1954 and 31-12-1984; - Conditional release no later than 30-06-2005 (this was extended to 19-09-2005 and again to 31-03-2006); - Swedish or Norwegian speaker; - Not having previously received BSF in remand or any other prison; - Heavy use of alcohol or drugs, measured by the standard prison and probation system: 1= occasional use; 2= heavy use; - ASI interview at intake; - No order for deportation after release from prison Exclusion Criteria: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Sweden | Karolinska Institutet, Dep Clin Neuroscience | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet | the research committee of the National Prison and Probation Administration |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | number of days with substance use | alcohol- or drug use as measured by the Addiction Severity Index (ASI) at intake and at 10 months after release | of the last 30 days | Yes |
Secondary | reported days of illegal activity | as measured by Addiction Severity Index at intake and 10 months after release | during the preceding 30 days | Yes |
Secondary | number of days working | as measured by the Addiction Severity Index at intake and 10 months after release | during the last 30 days | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03165942 -
Neuroendocrine Response to Oral Alcohol Administration
|
Phase 1 | |
Recruiting |
NCT05343039 -
Technology Enhanced Adolescent Mental Health (TEAM)
|
N/A | |
Active, not recruiting |
NCT04070521 -
EEG Monitoring in the Emergency Department
|
||
Completed |
NCT03169244 -
Buproprion for Binge Drinking
|
Phase 2 | |
Recruiting |
NCT05246202 -
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
|
N/A | |
Completed |
NCT05036499 -
PFI for Pain-Related Anxiety Among Hazardous Drinkers With Chronic Pain
|
N/A | |
Recruiting |
NCT04368416 -
Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
|
||
Not yet recruiting |
NCT04557631 -
Evaluation of the Threshold for the Interpretation of the Results of a Method for the Blood Determination of Phosphatidyléthanol
|
||
Terminated |
NCT00890149 -
Ondansetron for the Treatment of Heavy Drinking Among Emerging Adults
|
Phase 2 | |
Completed |
NCT02681406 -
Smartphone Based Continuing Care for Alcohol
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02448134 -
A Community-Based Strategy for Preventing Underage Drinking
|
N/A | |
Withdrawn |
NCT01847300 -
cSBI-M for Young Military Personnel
|
N/A | |
Withdrawn |
NCT01796158 -
Pilot Test of Computerized MET to Reduce Adolescent Alcohol Use
|
N/A | |
Withdrawn |
NCT01511679 -
Brain-imaging and Adolescent Neuroscience Consortium
|
N/A | |
Completed |
NCT01553136 -
Varenicline Treatment of Alcohol Dependence in Smokers
|
Phase 2 | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Withdrawn |
NCT01275391 -
cSBIRT to Reduce Teen Tobacco, Alcohol and Drug Use
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT01539525 -
Screening to Augment Referral to Treatment- Project START
|
Phase 2 | |
Completed |
NCT01207258 -
Brief Intervention for Problem Drinking and Partner Violence
|
Phase 2 |